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Abstract
Primarily arising from their well understood beneficial health effects, many lactobacilli strains are considered good
candidates for use as probiotics in humans and animals. Lactobacillar probiosis can itself be best typified by the
Lactobacillus rhamnosus GG strain, which, with its well-documented clinical benefits, has emerged as one of the most widely
used probiotics in the food and health-supplement industries. Even so, many facets of its molecular mechanisms and
limitations as a beneficial commensal bacterium still remain to be thoroughly explored and dissected. Because L. rhamnosus
GG is one of only a few such strains exhibiting surface piliation (called SpaCBA), we sought to examine whether this
particular type of cell-surface appendage has a discernible immunomodulating capacity and is able to trigger targeted
responses in human immune-related cells. Thus, presented herein for this study, we recombinantly engineered Lactococcus
lactis to produce native (and pilin-deleted) SpaCBA pili that were assembled in a structurally authentic form and anchored
to the cell surface, and which had retained mucus-binding functionality. By using these recombinant lactococcal constructs,
we were able to demonstrate that the SpaCBA pilus can be a contributory factor in the activation of Toll-like receptor 2-
dependent signaling in HEK cells as well as in the modulation of pro- and anti-inflammatory cytokine (TNF-a, IL-6, IL-10, and
IL-12) production in human monocyte-derived dendritic cells. From these data, we suggest that the recombinant-expressed
and surface-anchored SpaCBA pilus, given its projected functioning in the gut environment, might be viewed as a new
microbe-associated molecular pattern (MAMP)-like modulator of innate immunity. Accordingly, our study has brought some
new insight to the molecular immunogenicity of the SpaCBA pilus, thus opening the way to a better understanding of its
possible role in the multifaceted nature of L. rhamnosus GG probiosis within the human gut.
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Introduction
Gram-positive lactobacilli are recurrent members of the gut
commensal community and among the earliest inhabitants of the
gastrointestinal (GI) tract [1]. Stemming from the century-old
Metchnikoff concept of lactobacilli, a certain proportion of
intestinal strains, as well as isolates from other habitats, are used
routinely now as probiotics in humans and animals. Character-
istically, such bacteria are understood to possess a strong
propensity to help promote good health as well as alleviate a
variety of health problems [2–4]. However, to varying extents,
these types of lactobacilli are associated mainly with the fecal
stream and exist only briefly in the gut [5–7]. Thus, many
lactobacilli classified as probiotic are transient inhabitants and so
part of a temporal gut microbiome, as they find it difficult to
permanently colonize a specific niche in the intestine. However,
despite some genetic shortcomings associated with their overall
adhesion capacity, when such lactobacilli are replenished con-
stantly in high numbers in the gut, they can perform key functions
in sustaining a normal microbial balance and in helping to
preclude certain pathogen-borne infections [8].
Perhaps most significantly, many recent studies have begun to
scrutinize how important probiotic lactobacilli are as transitory,
but also targeted, inducers of protective host immunity, which in
many instances involve the various defense mechanisms of the
innate and adaptive immune systems [9]. For example, as it has
been reviewed in the literature recently [10–12], bacterial cell-
induced immunomodulation involving lactobacilli includes imme-
diate innate responses that can inhibit inflammation, regulate Toll-
like receptor (TLR) signaling, trigger natural killer (NK) cell
release, and stimulate maturation of antigen-presenting dendritic
cells (DCs). Delayed adaptive immune responses that are induced
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by lactobacilli have typically involved activating lymphocyte
proliferation, releasing gut-specific immunoglobulin, and affecting
the T helper-1 and -2 (Th1/Th2) balance [10–12]. Up to now, it is
commonly accepted these immune functions are induced by
probiotic lactobacilli via mechanisms that are likely strain-specific
and multifactorial in nature. Notwithstanding, many studies are
beginning to credit a variety of proteinaceous and carbohydrate-
like cell-surface components as being contributory to the specific
manner by which certain of these lactobacillar strains can elicit
host immune-related responses (for review, see [13]).
Lactobacillus rhamnosus GG is perhaps one of the best-known
paradigms of lactobacillar probiosis, having over the many years
been thoroughly investigated, both in vitro and in vivo (for review,
see [14]). Originally recovered from a healthy human gut, L.
rhamnosus GG has gone on to be widely used in various foods and
dietary supplements for its perceived health benefitting properties.
Consequently, it is recognized as one of the stalwart strains of the
probiotic industry. However, in spite of this, the molecular
mechanisms and limitations of L. rhamnosus GG as a beneficial
commensal bacterium are still far from completely understood.
For instance, while the various clinical benefits of L. rhamnosus GG
have already become well documented in the literature, relatively
few studies have characterized those specific traits responsible for
its immunomodulating capacity. Nonetheless, some recent work
has started to link the different immune-related actions to a
particular set of interesting niche factors. As an example, two
soluble proteins released from L. rhamnosus GG cells, called p75
and p40 (also known as Msp1 and Msp2, respectively [15,16])
have been shown to be responsible for the previously established
ability of cells to deter cytokine-stimulated cell death in the
intestinal epithelium, and which as a protective mechanism
involves the activation of the anti-apoptotic PI3K/Akt signaling
pathway [17–20]. Another interesting example involves the
galactose-rich exopolysaccharides (EPS) surrounding L. rhamnosus
GG cells, in which it was reported that because sub-inhibitory
levels of the antimicrobial peptide LL-37 could trigger EPS
production in cells, this layer of carbohydrate molecules is thought
to have a protective shielding function toward host innate immune
effectors [21]. Finally, one more example involves the lipoteichoic
acids (LTAs) in the cell wall of L. rhamnosus GG, which were
recently shown to stimulate TLR2/6-dependent activation of NF-
kB (nuclear factor-kappa beta) signaling in an human embryonic
kidney cell line (HEK293T) as well as induce pro-inflammatory
cytokine interleukin-8 (IL-8) mRNA expression in human intes-
tinal epithelial Caco-2 cells [22].
Somewhat recently, we identified L. rhamnosus GG as one of the
first probiotic strains known to be piliated [23]. This finding in
itself was viewed as intriguing given that previously the occurrence
of pili amongst Gram-positive bacteria was found primarily in
pathogenic strains and normally associated with their virulence
(for review, see [24]). We further revealed that the overall
structural arrangement of the L. rhamnosus GG pilus (called
SpaCBA) bears close resemblance to the typical three-pilin subunit
architecture of those already determined from other piliated
Gram-positive bacteria [25]. Most importantly, functionally
attributed to the SpaCBA pilus were the abilities to adhere
strongly to both human-derived intestinal mucus [23,26] and
Caco-2 cells [27] as well as to promote biofilm growth [27], all of
which might be considered the needed phenotypic traits of
probiotic lactobacilli that can likely help support increased
adhesion and longevity in the gut. However, although a functional
correlation between cell mucoadhesiveness and pili in L. rhamnosus
GG was basically established, a recent study using knockout
mutants had demonstrated that the SpaCBA pilus has also an
immunomodulating function in intestinal epithelial cells, albeit an
indirect one [27]. Therein, it was found that the SpaCBA pilus has
an apparent dampening effect on the mRNA levels of cytokine IL-
8, but whose direct induction was triggered initially by LTA,
possibly being mediated through a TLR2-dependent mechanism.
Still, a more recent study has inferred the possibility that SpaCBA
piliation might have a role in the TLR2-mediated NF-kB signaling
that was induced by L. rhamnosus GG, but not by two nonpiliated
Lactobacillus casei strains [28].
Because the potential role of pili from L. rhamnosus GG in
triggering key signaling pathways of inflammation is less than
resolved and even much less understood at the present time, we
sought to investigate further the immunomodulatory functioning
of the SpaCBA pilus by assessing its ability to stimulate certain
innate immune responses in human immune-related cells. For this,
instead of utilizing the traditional knockout-mutant approach, we
opted for a different strategy and genetically engineered the food-
grade Lactococcus lactis NZ9000 strain to produce SpaCBA pili.
Lactococcus species are themselves well known to be the cloning
workhorses of lactic acid bacteria (LAB) and have been employed
frequently in studies as the host for the recombinant expression of
many different proteins (for review, see [29–31]), including pili
from Gram-positive pathogens [32–34].
In our study presented herein, the cloning of L. lactis NZ9000
containing the L. rhamnosus GG spaCBA pilus operon was achieved
to produce the recombinant SpaCBA pilus in its native (and pilin-
deleted) functional form that was both authentic structurally and
fully assembled with all pilin subunits. Accordingly, by using these
recombinant constructs of piliated lactococci, the putative capacity
of SpaCBA pili for activating the TLR2-dependent NF-kB
signaling in HEK cells and modulating human monocyte-derived
dendritic cell (moDC) cytokine production was explored. From
these results, we suggest that the role of the surface-anchored
SpaCBA pilus can be expanded beyond just a simple mucus-
adherent function to one that now includes prospective involve-
ment as an adhesive potentiating modulator of innate immunity,
and which one can speculate might conceivably be manifested in
the gut environment.
Results and Discussion
Lactococcal surface expression of wild-type and pilin-
deleted SpaCBA pili
Genes for the SpaCBA pilus are arranged in the L. rhamnosus
GG genome as an operon (Figure 1A) and encode for three pilin
proteins (i.e., the major SpaA and the minor SpaB and SpaC
subunits) and the pilin-specific sortase, an enzyme that is needed
for pilus polymerization [23]. Based on our previous electron
microscopy-derived interpretations, the structural makeup of the
fully assembled SpaCBA pilus consists of a polymerized backbone
built of SpaA subunits, SpaC at the pilus tip, and the basal SpaB,
of which the latter two ancillary subunits are also positioned
irregularly along the length of the pilus structure [23,25].
To facilitate our studies on the immunomodulatory capacity of
SpaCBA pili, we first engineered a plasmid construct that allows
expression in L. lactis NZ9000 of a recombinant form of the wild-
type (WT) SpaCBA pilus similar in composition to that described
above. Here, the coding region of the spaCBA pilus operon was
inserted into a nisin-inducible expression vector (pKTH5080) to
generate recombinant plasmid pKTH5391, which was propagated
as the GRS1185 lactococcal construct (Figure 1A). To establish
whether pilus production took place after this lactococcal construct
was induced with nisin, cell wall-extracted proteins were recov-
ered, analyzed by immunoblotting with pilin-specific antiserum
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(anti-SpaA, anti-SpaB, or anti-SpaC), and then examined for a
characteristic high-molecular-weight (HMW) pattern, in which
compressed and laddered protein bands correspond to different
lengths of pili.
As shown in Figure 1B, HMW protein was observed on
immunoblots of cell wall-extracted proteins from nisin-induced
cells of GRS1185 with all individual anti-pilin sera (lane 4). The
most intense blotting signal was detected when anti-SpaA and
anti-SpaC sera were each used to probe the blots and rather unlike
that of SpaB-specific antibody, which in comparison gave a slightly
weaker response. As a positive control (lane 2), the same sort of
HMW banding pattern was also observed for cell wall protein
extracts from L. rhamnosus GG cells, although, consistent with our
earlier findings for SpaCBA pili [25], no HMW bands were visible
when anti-SpaB serum was used. However, with all anti-pilin sera
used, bands corresponding to the molecular weight size of the
monomeric form of the SpaA (,30 kDa), SpaB (,20 kDa), and
SpaC (,90 kDa) pilins were detected in GRS1185 cell wall
protein extracts (Figure 1B, lane 4) and as had been found in our
previous work [25]. Expectedly, no such bands for HMW or
monomeric protein could be detected in the negative control
empty vector-carrying GRS1052 construct (lane 3). Altogether,
these immunoblot data indicate that each of the three pilin
subunits (SpaA, SpaB, and SpaC) is a structural component of an
expressed and fully assembled cell wall-anchored WT pilus in L.
lactis.
To provide convincing visual evidence of surface localization for
recombinant WT SpaCBA pili in nisin-induced lactococcal cells,
we used immunogold labeling of pilin subunits and transmission
electron microscopy. Here, for example, the GRS1185 construct is
seen to possess a pilus structure extending outwardly from the cell
surface, which, based on detection with SpaA and SpaC antisera
in a double-labeling experiment (Figure 1C) and as would be
expected [25], is composed of a multitude of pilin subunits. On the
other hand, the use of anti-SpaB serum to visualize recombinant
pili proved less achievable given that rather few protein A-gold
particles were observed to be associated within each pilus fiber
(data not shown). Nonetheless, this was in line with not only our
immunoblotting results (see above), but also our previous work on
L. rhamnosus GG [25], in which we found that SpaB is more
underrepresented as a structural constituent within the pilus
backbone than the other two pilin types and instead mainly buried
within the cell wall as a basal subunit.
We also constructed three piliated deletion mutants in
lactococci, these of which include the SpaB-deleted GRS1195,
SpaC-deleted GRS1211, and double SpaB/SpaC-deleted
GRS1223 constructs (Figure 1A). In order to corroborate the
absence of expression for deleted pilins in these mutant constructs
during nisin-induced conditions, each was analyzed for their
respective monomeric proteins by immunblotting with all three
pilin-specific antisera. As can be seen for GRS1195 cell wall
protein extracts (Figure 1D, lane 4), aside from the predictable
bands that were detected with anti-SpaA and anti-SpaC sera, a
band was not observed when the blot was treated with anti-SpaB
serum, indicating that the SpaB pilin was not being expressed in
this lactoccocal construct. Likewise, analogous results were also
obtained when blots of cell wall proteins from cells of the
remaining two mutant constructs were probed with anti-pilin sera,
which confirmed that SpaC in GRS1211 (Figure 1D, lane 5) and
both SpaB and SpaC in GRS1223 (Figure 1D, lane 6) were not
being produced in these cells. Results obtained for pilin antiserum
blots of cell wall protein extracts from L. rhamnosus GG (Figure 1D,
lane 1) and GRS1052 (Figure 1D, lane 2), which had been used as
positive and negative controls, respectively, were as to be expected.
Figure 1. Characterization of recombinant-expressed L. rham-
nosus GG SpaCBA pili in L. lactis. (A) The coding region of the L.
rhamnosus GG spaCBA pilus operon and a summary of the nisin
promoter-regulated (PnisA) WT and pilin-deleted SpaBCA-piliated
recombinant constructs in L. lactis are depicted schematically. Genes
for the pilin subunits (spaA, spaB, and spaC) and pilin-specific sortase
(srtC1), including those genes that are deleted (6) in the recombinant
constructs, are indicated. Identities for the various SpaCBA-piliated
lactococcal constructs (GRS1185, GRS1195, GRS1211, and GRS1223),
including the spaCBA pilus operon-containing plasmids they each
propagate (pKTH5391, pKTH5497, pKTH5413, and pKTH5440, respec-
tively), are indicated. (B) Immunoblot analysis of cell wall-extracted
proteins recovered from L. rhamnosus GG (lane 2), the empty vector
(pKTH5080)-carrying GRS1052 L. lactis construct (lane 3), and the nisin-
induced WT SpaCBA-piliated GRS1085 L. lactis construct (lane 4) probed
with the various pilin-specific antisera (anti-SpaA, anti-SpaB, or anti-
SpaC, as indicated). Asterisks on the right of each immunoblot indicate
the presumed location of monomeric SpaA, SpaB, and SpaC pilin
proteins. The compressed and laddered region of high-molecular-
weight (HMW) protein bands representing various lengths of pili is
indicated on the left. Molecular weight markers (lane 1) and their
positions are indicated on the left. (C) Immunogold double-labeling
electron microscopy of WT SpaCBA-piliated lactococcal cells (GRS1185)
using SpaA antiserum with protein A-10-nm gold particles as well as
SpaC antiserum with protein A-5-nm gold particles is shown. The
location of 5-nm (white arrow) and 10-nm (black arrow) gold particles
on the pilus structure are indicated. (D) Immunoblot analysis of cell
wall-extracted proteins recovered from L. rhamnosus GG (lane 1) and
the empty vector (pKTH5080)-carrying GRS1052 L. lactis construct (lane
2), as well as the nisin-induced WT (GRS1085) (lane 3), SpaB-deleted
(GRS1195) (lane 4), SpaC-deleted (GRS1211) (lane 5), and SpaB- and
SpaC-deleted (GRS1223) (lane 6) piliated L. lactis constructs probed with
anti-SpaA, anti-SpaB, or anti-SpaC sera, each of which is indicated on
the left of the respective immunoblot. Positions of monomeric SpaA
(,31 kDa), SpaB (,21 kDa), and SpaC (,91 kDa) protein bands are
marked by an asterisk on the right of corresponding immunoblots.
doi:10.1371/journal.pone.0064416.g001
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Immuno-electron microscopic analyses for some of the pilin
deletion mutants with SpaA antiserum indicated that these
constructs were still able to display polymerized cell surface-
localized pili (data not shown). However, given that the basal SpaB
pilin is likely seen as the controlling factor that terminates the
polymerization process and signals the covalent cell wall-attach-
ment of pili [25], it is not certain whether this missing subunit in
GRS1195 and GRS1223 causes pili in such cells to be only
membrane bound through an interaction with the pilin-specific
sortase.
Mucus adhesion capacity of recombinant SpaCBA-
piliated lactococcal constructs
Previously, we demonstrated that the adhesive interaction
between L. rhamnosus GG and human intestinal mucus was, in
addition to other surface adhesins [35,36], strongly dependent
upon the SpaCBA pilus, with the main mucus-binding determi-
nant shown to be the SpaC pilin [23,26]. Interestingly, an
adherent but perhaps novel ability to bind mucus was also
attributed to recombinant-produced basal SpaB protein, which
unexpectedly involved electrostatic interactions [26]. With this in
mind, we sought to authenticate lactococcal-expressed SpaCBA
pili by assessing the level of mucoadhesiveness for the recombinant
WT and various pilin deletion constructs.
As indicated in Figure 2, nisin-induced GRS1185 cells
producing WT SpaCBA pili could bind to human intestinal
mucus at levels that, while not identical, were similar enough to
that measured for L. rhamnosus GG cells (positive control). We
reasoned that, despite the fact the number of cells had been
normalized for the assay, the proportion of surface-localized pili
per cell for these two piliated bacteria is variable and not
matching, and thus obtaining mucus adherence at the exact same
levels is likely a random or more so unachievable outcome. For
instance, sometimes an inherent drawback of a peptide-inducible
recombinant protein expression system is the stability of the
inducing agent being used. Given that proteinaceous nisin is less
stable at physiological pH (and here the pH of the growth medium
used), it might be viewed somewhat less effective than, for
example, a more robust and stable chemical inducer. Conse-
quently, this could be one explanation for our electron microscopic
observations of mixed populations of recombinant lactococci
having a range of pili per cell (data not shown). Nonetheless, for
the recombinant SpaCBA pilus itself, the level of binding to mucus
is clearly higher than that obtained for the negative controls
GRS71 and GRS1052. Thus, based on these results one can be
reasonably assured that the recombinant SpaCBA pilus in L. lactis
and the native form in L. rhamnosus GG share similar mucus
adhesion functionalities.
Taking into account the adherent properties of SpaC and SpaB
in L. rhamnosus GG as above described, we also assessed the
functional changes imparted to the SpaCBA pilus in the three pilin
deletion mutant constructs (GRS1195, GRS1211, and GRS1223)
by measuring each of their abilities to bind mucus. For the nisin-
induced GRS1211 (DspaC) and GRS1223 (DspaB and DspaC)
constructs (Figure 2), each of which no longer encode for the SpaC
pilin, both exhibited mucus adhesion at levels near the negative
controls (see above), thus verifying that the functionality of SpaC is
absent in the corresponding surface-expressed pili. However, for
GRS1195 (DspaB) the deletion of SpaB did not seem to affect the
mucus-binding capacity of this construct, whose own levels were
nearly identical to that of GRS1185 and even though we reported
previously that recombinant-produced SpaB protein could adhere
to mucus [26]. However, we consider this finding fully consistent
with our previous work [26], in which mucosal adhesion was not
blocked when L. rhamnosus GG cells were pretreated with anti-
SpaB serum, a result we had assumed was due largely to the less
accessible location of SpaB at the pilus base. At any rate, the
continued high level of mucus adherence observed with GRS1195,
together with the results obtained with the GRS1211 and
GRS1223 constructs, reaffirms the key role played by SpaC as
the main mucus-binding determinant of the SpaCBA pilus.
TLR2-mediated innate immune signaling by recombinant
SpaCBA-piliated lactococcal constructs
The innate immune system relies on the ability of a relatively
large collection of pattern recognition receptors (PRRs) to identify
certain conserved bacterial ligands, known collectively as microbe-
associated molecular patterns (MAMPs) [13,37,38]. Among the
PRRs, TLR2 has specificity for a structurally diverse repertoire of
MAMPs (i.e., peptidoglycan, lipoteichoic acid, and lipoprotein) in
Gram-positive bacteria, which functionally is reliant on heterodi-
mer formation with either TLR1 or TLR6 [13,38]. Interestingly, a
quite recent study has now demonstrated that the type 1 pilus from
Streptococcus pneumoniae is a TLR2 agonist and can be considered an
important determinant for TLR2-dependent induction by this
particular Gram-positive pathogen [39]. Similarly, it has recently
been inferred that the SpaCBA pilus in L. rhamnosus GG might be a
determining factor that helps this bacterium trigger TLR2-
activated NF-kB responses [28].
For this part of our study, we used the WT (GRS1185) and
deletion mutant (GRS1195, GRS1211, and GRS1223) recombi-
nant lactococcal constructs to assess whether the proteinaceous
SpaCBA pilus can be recognized specifically by TLR2. Here, we
initially examined the ability of nisin-induced GRS1185 to
stimulate a stably co-transfected HEK293 cell line that contains
the genes for human TLR2 and a NF-kB-regulated secreted
alkaline phosphatase (SEAP) reporter system, the latter of which
facilitates the monitoring of TLR2 signaling. Serving as a positive
Figure 2. Binding of recombinant SpaCBA-piliated lactococcal
cells to human intestinal mucus. The adhesion of metabolically
labeled (3H) cells from normalized cultures of recombinant SpaCBA-
piliated lactococcal constructs (GRS1185, GRS1195, GRS1211, and
GRS1223), along with vectorless (GRS71) and empty vector (GRS1052)
L. lactis NZ900 as negative controls and L. rhamnosus GG (GG) as a
positive control, to human intestinal mucus was performed according
to the method outlined in Materials and Methods. Measurements were
done in quadruplicate and the experiment was performed three times.
Error bars represent standard error of mean (SEM). Differences between
data (GRS1185, GRS1195, or GRS1211) from pairwise comparisons
against GRS71 data are regarded as extremely significant (P,0.001),
with the exception of data from GRS1223, which was deemed not
significant (P.0.05).
doi:10.1371/journal.pone.0064416.g002
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control, NF-kB activation was readily detected when HEK-TLR2
cells were treated with the TLR2-agonist lipopeptide Pam3CSK4
(1 ng/ml), while with the empty vector GRS1052 and vectorless
GRS71 negative controls, NF-kB was activated at only low levels
(Figure 3). However, NF-kB activation in HEK-TLR2 cells was
considerably induced by the SpaCBA-piliated GRS1185 con-
struct, thus indicating the specific stimulation of TLR2-dependent
activity (Figure 3). Of note, it is worth mentioning that in similar
experiments with ‘‘LPS-specific’’ HEK-TLR4 and ‘‘flagellin-
specific’’ HEK-TLR5 cells, we observed that GRS1185-induced
NF-kB activity was not detected (data not shown).
Despite the removal of the SpaB and SpaC pilins from the pili
in GRS1195, GRS1211, and GRS1223 deletion mutants, all these
constructs remained potent and still induced NF-kB activation in
HEK-TLR2 cells at levels largely identical to that detected with
WT-piliated GRS1185 (Figure 3). Such results would seem to
suggest that TLR2 is specific for the recognition of the overall
three-pilin macromolecular protein-fold architecture of polymer-
ized subunits and less so, those individual minor pilin constituents
located at the tip or base of the pilus structure. Then again, and
somewhat supportive of this, it has recently been reported that
while the tip-located adhesive pilin (RrgA) of the pneumococcal
type 1 pilus is specifically responsible for TLR2-dependent
activation, it was only optimal when this protein is in the
structured form of macromolecular aggregates and not as
monomeric protein [39].
To gain some indication whether the surface-associated factor
in recombinant lactococci that augments TLR2-dependent
activation is indeed proteinaceous in nature, we repeated the
above experiment using heat treated nisin-induced GRS1185
bacteria (including those of GRS1052 as a control) (Figure 4).
Besides monitoring NF-kB activation in the spent culture
supernatant, we also checked for the production of IL-8, whose
secretion occurs in various cell types, including epithelial cells, and
which can be induced by the presence of microbial products. As
detected with GRS1185, heat treatment sufficient to denature
protein folding had noticeably reduced NF-kB activation in HEK-
TLR2 cells (Figure 4A). Importantly, when live GRS1185 bacteria
had been subjected to heat treatment, the normal induction in
HEK-TLR2 cells of secreted IL-8 protein (an endogenous effector
molecule of these cells) was then abolished (Figure 4B). Taken
together, these results support the involvement of heat-labile
proteins and might entail the participation of SpaCBA pili in
triggering such TLR2 responses.
In an experiment to demonstrate whether these TLR2 actions
rely on a surface-associated protein attached firmly to the cell wall
as opposed to a protein product released from the recombinant
lactococcal cells, we used Transwell cell culture membrane inserts
(0.4-mm pore size) to partition the GRS1185 and HEK-TLR2 cells
from each other, thus precluding any direct cell-to-cell contact.
With the Transwell system (Figures 5A and 5B), both NF-kB
activation and IL-8 production were only at the background levels
of the DMEM control in those HEK-TLR2 cells separated from
nisin-induced GRS1185 cells. Such results would seem to indicate
Figure 3. TLR2-mediated immune responses induced by
recombinant SpaCBA-piliated lactococcal cells. Stimulation of
TLR2-dependent NF-kB activation in the HEK-TLR2 cell line by
normalized cultures of recombinant SpaCBA-piliated lactococcal cells
(GRS1185, GRS1195, GRS1211, and GRS1223) was carried out according
to the method described in Materials and Methods. GRS71 and
GRS1052 lactococcal cells as well as DMEM cell culture media were
included as negative controls. TLR2-agonist lipopeptide Pam3CSK4
(1 ng/ml) was used a positive control. Measurements were done in
quadruplicate and the experiment was performed three times. Error
bars are standard error of mean (SEM). Differences between data
(GRS1185, GRS1195, GRS1211, or GRS1223) from pairwise comparisons
against GRS71 data are considered extremely significant (P,0.001).
doi:10.1371/journal.pone.0064416.g003
Figure 4. Effect of heat-treated WT SpaCBA-piliated lactococcal
cells on TLR2-dependent immune activity. Stimulation of TLR2-
dependent NF-kB activation (A) and IL-8 cytokine production (B) in the
HEK-TLR2 cell line by either live (-) or heat-treated (100uC for
10 minutes) (+) WT SpaCBA-piliated lactococcal cells (GRS1185) was
performed as described in Materials and Methods. Live and heat-treated
GRS1052 lactococcal cells were also tested. DMEM cell culture media,
Pam3CSK4 (1 ng/ml), and E. coli lipopolysaccharide (LPS; 1 ng/ml) were
included as controls. Quadruplicate and duplicate measurements for
NF-kB activation and IL-8 production, respectively, were performed.
Error bars indicate standard error of mean (SEM). Differences between
GRS1185 and GRS1052 data are deemed extremely significant
(P,0.001).
doi:10.1371/journal.pone.0064416.g004
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the formation of local cell-to-cell interactions are needed for these
TLR2-related immune responses, whose stimulation possibly
involves a cell-wall anchored protein. Here, the SpaCBA pilus,
via its adherent capacity, conceivably might help maintain a close
association between the HEK-TLR2 and GRS1185 cells. In this
regard, one might begin to ask whether such increased adhesion
between ‘‘host immune’’ and ‘‘piliated target’’ cells can then lead
to enhanced immunomodulatory activity in the context of the gut
environment.
Speculatively, based on the ability of the SpaCBA-piliated
lactococcal constructs to induce TLR2-dependent responses, it
would seem reasonable to suggest that the surface-anchored
SpaCBA pilus is most likely acting as a TLR2 agonist or activator.
This would not only help corroborate the role of the SpaCBA pilus
in the TLR2-dependent NF-kB activity of L. rhamnosus GG that
had been inferred earlier [28], but also lend support to the putative
TLR2-related functionality of SpaCBA pili in balancing the levels
of LTA-induced IL-8 mRNA expression as had been demonstrat-
ed in a previous study [27]. Moreover, with this now the SpaCBA
pilus can be included with cell wall LTAs in L. rhamnosus GG [22]
as an immunomodulator with some element of discernible TLR2
agonist activity. However, most notably for this type of elongated
surface-localized structure, our data supporting the possible new
agonist function for the SpaCBA pilus in TLR2-regulated
signaling would be in good agreement with what was reported
recently (see above) for the type 1 pilus from the S. pneumoniae
pathogen [39].
Stimulation of DC cytokine production by recombinant
SpaCBA-piliated lactococcal constructs
Antigen-presenting DCs are a heterogeneous population of
immune cells that link innate and adaptive immune responses and,
in effect, can help to control the homeostatic balancing of immune
activation, tolerance, and suppression in the gut [37,40]. DC
activity can be mediated by the recognition of MAMPs in both
commensal and pathogenic bacteria through a variety of host
receptor systems, including the TLRs. Here, immature DCs
undergo a maturation process that includes the up-regulated
expression of cell-surface markers (e.g., CD83 and CD86), and
where, in the end, mature DCs become very potent at cytokine
production, which in itself is important for interactions among
other immune cells [40]. Significantly, the role of DCs in the
immune interactions of probiotic lactobacilli has been demon-
strated [41], with the results from numerous studies having
implicated some strains in also modulating DC surface expression
and cytokine production (for review, see [9,42,43]).
Accordingly, we decided to test the stimulatory effect of the
recombinant SpaCBA-piliated lactococcal constructs on the
production profile of various cytokines in human moDCs. In
experiments performed with a predetermined optimal amount of
lactococci (MOI 100), moDCs that were stimulated with SpaCBA-
piliated GRS1185 cells had increased production levels for all four
cytokines tested (i.e., TNF-a, IL-12, IL-10, and IL-6; Figures 6A-
D, respectively). As to be anticipated, such production levels were
not detected when moDCs were treated with the GRS71 and
GRS1052 negative controls. Likewise, in comparison with the
GRS1185 results, stimulation of moDCs by the three pilin deletion
lactococcal constructs (GRS1195, GRS1211, and GRS1223) also
give rise to reduced production of the four different cytokines.
Noteworthy, however, the GRS1195 construct, which expressed
SpaB-deleted pili, could stimulate cytokine production at about
half the level seen with GRS1185-induced stimulation, but with
the SpaC-deleted GRS1211 and SpaB- and SpaC-deleted
GRS1223 constructs, cytokine induction in moDCs had only
reached levels near what was observed for the negative controls. It
would seem that because the removal of SpaC from the assembled
pilus can cause a much more pronounced reduction in the levels of
produced cytokines, this adherent pilin subunit might be an
important determinant in SpaCBA pilus-induced cytokine re-
sponses by moDCs, and also what one might foresee is linked in
part to its adhesive capacity.
Also in this part of the study, we decided to test whether the
various SpaCBA-piliated lactococcal constructs would lead to
differential DC maturation. Here, although the expression levels of
three cell-surface marker proteins (CD83, CD86, and DC-SIGN)
had changed when moDCs were stimulated with GRS1185 as
opposed to GRS1052, on the whole these differences were only
minimal (data not shown). Likewise, lactococcal cells with SpaCBA
pili lacking SpaB or SpaC appeared to have no effect on the
maturation profile (data not shown).
Considering the commonly understood short half-life function-
ality of most cytokines and thus their need to be released locally to
work effectively, it is generally requisite that a close proximity be
maintained between host and target cells. With this in mind, one
can again speculate that the adhesiveness property of SpaCBA pili
could be related to the enhanced cytokine responses in the
Figure 5. Influence of cell-to-cell interactions on TLR2-depen-
dent immune responses induced by WT SpaCBA-piliated
lactococcal cells. Stimulation of human TLR2-dependent NF-kB
activation (A) and IL-8 cytokine production (B) in the HEK-TLR2 cell
line by WT SpaCBA-piliated lactococcal cells (GRS1185; MOI 625), either
non-partitioned (-) or partitioned (+) with Transwell membranes (0.4-mm
pore size), was carried out as outlined in Materials and Methods.
GRS1052 lactococcal cells (MOI 625) and DMEM cell culture media were
included as negative controls. Measurements were conducted in
quadruplicate and each experiment was carried out three times. Error
bars reflect standard error of mean (SEM). Differences between GRS1185
and GRS1052 data are considered significant (P,0.05).
doi:10.1371/journal.pone.0064416.g005
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moDCs. This would be manifested by the improved cell-to-cell
contact that is expected to occur when such immune cells are
treated with SpaCBA-piliated lactococci rather than the non-
piliated form. In support of the above-stated idea, we performed
an experiment to examine whether the induced DC secretion for
one of the tested cytokines (i.e., TNF-a) would be affected when
physical contact between moDCs and cells of the various
recombinant lactococcal constructs is prevented. Once again,
using the Transwell system to restrict direct cell-to-cell interac-
tions, such that moDCs and WT or mutant SpaCBA-piliated
lactococcal cells are placed in the lower and upper compartments,
respectively, we found that we could no longer detect any TNF-a
responses in this situation (Figure 7). We regard such results as
indicative of a soluble factor not being involved in triggering
cytokine production in these moDCs and instead that the
juxtaposed positioning of host and target cells is essential. In such
a context, this might mean a surface-localized and adhesive
component like the SpaCBA pilus could help better position cells
close enough together so that either pili themselves or in
combination with some other surface molecules can perhaps act
as the signaling stimuli for cytokine induction in moDCs.
In our experiments, we chose to examine a panel of pro- and
anti-inflammatory cytokines that are among those used commonly
for gauging what immunomodulating affect various commensal
(and pathogenic) bacteria have on different DCs. Broadly
interpreted, the pattern of up-regulated DC cytokine production
we obtained with GRS1185 cells, and in correlation, the WT
SpaCBA pilus, was generally balanced between pro-inflammatory
(TNF-a, IL-6, and IL-12) and anti-inflammatory (IL-10) types. As
an overall pattern of cytokine production, this has been basically
seen in the findings of similarly performed studies involving
commensals and herein our study suggests induced homeostatic
basal-level responsiveness in moDCs when being challenged by the
SpaCBA-piliated lactococci. However, surprisingly enough, while
a previous study on the immunomodulatory action of L. rhamnosus
GG had found this strain to be a relatively poor inducer of moDC
cytokine responses [44], and to the same extent what was also
Figure 6. Induction of cytokine production in humanmoDCs by
recombinant SpaCBA-piliated lactococcal cells. Stimulation of
TNF-a, IL-12, IL-10, and IL-6 cytokine production (A, B, C, and D,
respectively) in human moDCs by normalized cultures of recombinant
SpaCBA-piliated lactococcal cells (GRS1185, GRS1195, GRS1211, and
GRS1223) was carried out according to the method described in
Materials and Methods. Cells from GRS71 and GRS1052 L. lactis were
included as negative controls. RPMI cell culture media and E. coli
lipopolysaccharide (LPS; 1 mg/ml) were also included as controls.
Measurements were carried out in quadruplicate and each experiment
was done three times with moDCs from four different donors, with the
data used being the most representative of the experiments. Error bars
indicate standard error of mean (SEM).
doi:10.1371/journal.pone.0064416.g006
Figure 7. Effect of cell-to-cell interactions on TNF-a production
in human moDCs induced by recombinant SpaCBA-piliated
lactococcal cells. Stimulation of TNF-a production in human moDCs
by normalized cultures of recombinant SpaCBA-piliated lactococcal cells
(GRS1185, GRS1195, GRS1211, and GRS1223), either non-partitioned (-)
or partitioned (+) with Transwell membranes (0.4-mm pore size), was
done as outlined in Materials and Methods. GRS71 and GRS1052
lactococcal cells and RPMI cell culture media were included as negative
controls. Measurements were performed in quadruplicate and the
experiment was carried out with moDCs from four different donors.
Error bars are standard error of mean (SEM).
doi:10.1371/journal.pone.0064416.g007
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observed in our study (data not shown), we showed that the
recombinant lactococcal GRS1185 construct, or in effect the WT
SpaCBA pilus, can stimulate a relatively marked increase in the
production of the tested DC cytokines. Interestingly, L. lactis is
itself reported to be a comparatively good inducer of cytokines in
human- and murine-derived DCs [44,45], but here in our study it
would seem that the extra cell-surface localization of the SpaCBA
pilus structure has an additive potentiating effect on lactococcal-
induced changes in the cytokine production profile.
It is worthy of mention that it remains unclear to us the
peculiarity of behavior attributed to L. rhamnosus GG in earlier
work [44], as well as what we had also encountered (data not
shown). Here, despite having such quasi ‘‘immuno-potent’’
SpaCBA pili of its own, L. rhamnosus GG can seemingly provoke
only weak basal level moDC cytokine responses, those of which
were much lower than what levels we observed being potentiated
with WT SpaCBA-piliated lactococcal cells. However, be that as it
may, the low cellular immunostimulating activity reported for L.
rhamnosus GG generally falls within the realm of the borderline
immune status of most gut commensal bacteria, and, as expected,
is profoundly unlike the intense immunogenicity normally
associated with many intestinal pathogens.
Then again, based on our previous electron microscopic
observations [25], nothing seen visually (e.g., the EPS layer) on
L. rhamnosus GG cells appears to hinder SpaCBA pili from being
readily exposed exteriorly to the surrounding environment, thus
fulfilling what can be considered one of the necessary physical
preconditions for allowing a stimulatory effect on immune cells.
For that reason, we are also inclined to consider that a certain
degree of fluctuation or variation in protein production per cell
can occur in different bacterial expression hosts, so that, for
example, SpaCBA pili become more over-expressed in nisin-
regulated recombinant lactococci than what is localized on the cell
surface of L. rhamnosus GG by constitutive means. As such, this
could be reflected in the magnitude of induced DC cytokine
responses by these same piliated but different expression hosts. Still
though, it is clear to us that the SpaCBA pilus, via its recombinant
expression, has the unmistakable ability to potentiate further the
level of immunogenic responsiveness by DCs already associated
toward L. lactis.
Conclusion
Since the rather recent discovery of pilus structures in L.
rhamnosus GG, functional insights into the role of these so-called
SpaCBA pili in the probiosis of this intestinal lactobacillar strain
are only beginning to become more apparent. To further help in
an understanding of their possible part played within the gut
immune system, we engineered the functional recombinant
expression of fully assembled WT and pilin-deleted SpaCBA pili
in a L. lactis host strain. These piliated lactococcal constructs
proved to be a useful tool for testing the stimulatory effects of
SpaCBA pili on TLR2-dependent activities and on DC cytokine
production. In so doing, this then has given us some indication of
the possible immune function that surface piliation can perhaps
offer L. rhamnosus GG. For instance, we suggest that the surface-
anchored SpaCBA pilus, as expressed in recombinant form in
lactococcal cells and in the context of its projected functioning in
the gut, plausibly might be considered a type of MAMP-targeted
modulator of innate immunity. Such a novel role would be
consistent with the apparent functionality as a TLR2 agonist
reported recently for the type 1 pilus from S. pneumoniae [39]. Thus,
our results offer a degree of support for the importance of the
SpaCBA pilus, particularly the SpaC adhesin pilin subunit, as a
signaling entity that helps elicit innate immune activity.
Moreover, based on the findings of this current study and those
of an earlier one [27], the SpaCBA pilus can be added to the
growing number cell-surface features of L. rhamnosus GG that have
an immunomodulating function (i.e., EPS [21], LTA [22], and the
p75 and p40 proteins [17-20]). Accordingly, this would strengthen
the evidence for the multifactorial nature of the host cell interplay
of this particular strain. As a possible role in vivo, one can be
speculative and envisage that through the basal stimulatory actions
of SpaCBA pili on immune-related cells, for instance similar to
what we observed with the moDC modulation of inflammatory
cytokines, this type of cell-surface appendage might bring about a
pre-sensitized immune condition that, in the end, can allow the
host to better target and combat various gut-invading piliated
pathogens. However, remaining unclear is in what manner and to
what extent these surface-localized pili, implicit via a multifactorial
contribution, would have as a moderating function in helping the
gut immune system maintain the basal-level recognition and
tolerance of L. rhamnosus GG as an overall less ‘‘immuno-intrusive’’
intestinal bacterium. Finally on this last point, and to conclude, it is
expected that future studies on furthering such aspects should
likely shed added light on the molecular immunogenicity of the
SpaCBA pilus and by this then eventually provide a clearer picture
whether this type of surface piliation does in fact contribute to the
health-related functioning of L. rhamnosus GG in the human gut.
Materials and Methods
Bacteria, plasmids, growth media, and culture conditions
Lactococcus lactis NZ9000 (pepN::nisRnisK) [46], a derivative strain
of L. lactis MG1363, and herein called GRS71, was grown
overnight at 30uC with M17 medium (Difco) containing 0.5%
glucose (GM17) on agar plates or statically in liquid broths, and
was supplemented with 7.5 mg/ml chloramphenicol when needed
for recombinant pilus production. Lactobacillus rhamnosus GG
(ATCC 53103) was grown overnight at 37uC with de Man-
Rogosa-Sharpe (MRS) medium (Difco) on agar plates or statically
in liquid broths. Plasmid pKTH5080 (unpublished) was used for
cloning in L. lactis and was derived from pNZ8032 [47], a
lactococcal expression vector that contains regulatory genes (nisR
and nisK) for nisin-inducible gene expression from the PnisA
promoter, and which, for our cloning, was subsequently
engineered to contain added sequences for the Lactobacillus brevis
S-layer protein (SlpA) secretion signal and transcriptional termi-
nator and for two additional restriction endonucleases (EcoRI and
XhoI) in the multiple cloning region.
DNA isolation and manipulations
The isolation of plasmid DNA from L. lactis using the QIAprep
Spin Miniprep Kit (Qiagen) and genomic DNA from L. rhamnosus
GG using the Wizard Genomic DNA Purification Kit (Promega)
were both performed with slight modifications using the manu-
facturer-recommended protocols. Established DNA methods were
used for molecular cloning, PCR amplification, restriction
endonuclease digestion, DNA ligation, and other related tech-
niques.
Lactococcal cloning of expression constructs for SpaCBA
pilus production
Construction of a lactococcal expression plasmid containing the
L. rhamnosus GG four-gene spaCBA pilus operon, which includes
the LGG_00444 (spaC), LGG_00443 (spaB), LGG_00442 (spaA),
and LGG_00441 (srtC1) open reading frames (ORFs) [23], was
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carried out by overlap extension PCR (OE-PCR) [48] using
oligonucleotide primers (Oligomer, Finland) listed in Table 1.
With genomic DNA from L. rhamnosus GG as the template, an
upstream OE-PCR fragment encoding about two-thirds of the
spaC gene (including sequence for its own secretion signal peptide)
was PCR amplified using forward primer 1986 and reverse primer
1988. A flanking downstream OE-PCR fragment encoding the
remaining third of the spaC gene and all of the spaB, spaA, and
srtC1 genes was PCR amplified using forward primer 1985 and
reverse primer 1989. Primers 1985 and 1988 were each designed
to also introduce point mutations for the removal of an NcoI
restriction site within the coding region of the spaC gene. The
upstream and downstream OE-PCR fragments were then
reconnected in-frame as the intact spaCBA pilus operon, which
encodes for the SpaC, SpaB, and SpaA pilin subunits and the
sortase-C1 enzyme, by a final PCR step using NcoI-containing
forward primer 1984 and XhoI-containing reverse primer 1987.
The final amplified PCR fragment, digested with NcoI and XhoI
restriction endonucleases, was ligated into the pKTH5080
lactococcal nisin-inducible expression vector, which was subse-
quently electroporated into competent L. lactis NZ9000 cells as
performed previously [49] and the transformants then selected for
their antibiotic resistance on GM17 agar media containing
7.5 mg/ml chloramphenicol. PCR analysis and DNA sequencing
confirmed transformant clones with plasmids containing the
correct insert. A lactococcal clone with the right plasmid construct
(designated pKTH5391) was chosen and called GRS1185.
A similar OE-PCR approach using genomic DNA was also
undertaken to generate lactococcal clones expressing SpaB or
SpaC pilin-deleted SpaCBA pili. A plasmid construct
(pKTH5497) that lacks the spaB gene in the spaCBA pilus operon
was obtained by connecting an upstream fragment encoding spaC
(PCR amplified with forward primer 1986 and reverse primer
1981) to a downstream fragment encoding a 16-residue C-terminal
portion of spaB and the spaA and srtC1 genes (PCR amplified with
forward primer 1990 and reverse primer 1989) by PCR
amplification with primers 1984 and 1987. For generating the
spaC-deleted plasmid construct (pKTH5413), pairwise 1986
(forward) and 2110 (reverse) primers and pairwise 2109 (forward)
and 1989 (reverse) primers were used for obtaining their respective
upstream and downstream PCR fragments, which then were PCR
amplified with primers 1984 and 1987. The spaB-spaC double-
deletion plasmid construct (pKTH5440) was generated using
pKTH5413 plasmid DNA as the template. Here, an upstream
PCR fragment, which was PCR amplified with forward primer
1834 and reverse primer 1991, and a downstream PCR fragment,
which was PCR amplified with forward primer 1990 and reverse
primer 1016, were reassembled by PCR with primers 1834 and
1016. Final amplified PCR fragments representing the three
different pilin deletion constructs were first digested with NcoI and
XhoI and then each was ligated into pKTH5080, after which all
were transformed into L. lactis NZ9000 and selected as above
described. Following their confirmation by PCR screening and
DNA sequencing, the resulting lactococcal mutant clones were
called GRS1195 (DspaB), GRS1211 (DspaC), and GRS1223 (DspaB
and DspaC). L. lactis GRS1052 (unpublished), which carried the
empty vector pKTH5080, was used as a control.
Lactococcal production of recombinant SpaCBA pili
Starter cultures of recombinant L. lactis constructs (GRS1185,
GRS1195, GRS1211, GRS1223, and GRS1052) were normally
grown statically overnight at 30uC in GM17 liquid broths that
included 7.5 mg/ml chloramphenicol, and after being diluted
1:200 in the fresh tubes of the same growth medium, were grown
at 30uC to an optical density at 600 nm (OD600) of about 0.4. At
this point, pilus protein production was induced by adding nisin
(,0.5 to 5 ng/ml) to the culture, which was then allowed to
continue growing overnight. Cells were recovered by low speed
centrifugation (,5,000 6 g), after which cell pellets were
resuspended in a buffer suitable for their intended use.
Immunoblotting and immuno-electron microscopy
Nisin-induced cultures of L. lactis constructs were cell fraction-
ated according to a protocol described earlier for L. rhamnosus GG
[25]. Isolated cell wall-bound proteins were separated by SDS-
PAGE and pili were detected by immunoblotting with antiserum
raised against recombinant SpaCBA pilin proteins [26] as
described previously [25]. Immunogold labeling of SpaCBA-
piliated cells (recombinant lactococcal constructs and L. rhamnosus
GG) and transmission electron microscopic analyses were
performed essentially as described previously [25].
Table 1. PCR oligonucleotide primers used for lactococcal cloning.
Primer DNA Sequence (5’ to 3’)
1016 GTTCGGTACCATCAACAAAGCTCACCTA
1834 ACTTGAGATCTGACCTAGTCTTATAACTATACTGACAAT
1984 GTAAAATTTACGACCATGGCAGCTAAAGTG
1985 CAATGGCAATATCACGGCACAAAGGAC
1986 ATTGTCGCTTTACTGCGATGAAGCTTCTG
1987 GGATATTAAACAAATCTCGAGATCTTAATGATATTC
1988 GTCCTTTGTGCCGTGATATTGCCATTG
1989 AGACGGCTTCCACTATGGAAAGTCATC
1990 GACGGGTGGTGAAGCAACATGACTAAATCGCTCGGGTTGATAATCTTCGCGAC
1991 GTCGCGAAGATTATCAACCCGAGCGATTTAGTCATGTTGCTTCACCACCCGTC
2109 CTGGGCATTTGTTCGCGGTCTTATTGATTGCACTGGGATTGATCAGCGCAGCGTTC
2110 GAACGCTGCGCTGATCAATCCCAGTGCAATCAATAAGACCGCGAACAAATGCCCAG
Sequences for NcoI (1984) and XhoI (1987) restriction endonucleases used to facilitate cloning are underlined
doi:10.1371/journal.pone.0064416.t001
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Mucus adhesion assays
Human intestinal mucus served as the substrate for adhesion
assays (whose use was established previously [50]) and was
obtained surgically as resected tissue from patients with operable
colorectal cancer. As described previously [51], the mucus gel
layer was recovered from sections of noncancerous tissue
containing intact mucosa. The adhesion of nisin-induced recom-
binant lactococcal cells to intestinal mucus was carried out
according to a method described earlier [23,26], in which for
the assay used the cells are metabolically radiolabeled with
tritiated thymidine and the cell numbers are normalized to an
OD600 of 0.25. A detailed description of the assay conditions and
protocol has been provided elsewhere [23,26].
Ethics Statement
The Hospital District of Southwest Finland ethics committee
authorized and approved the use of human tissue specimens for
mucus isolation and those patients involved had been informed
beforehand and given their written consent.
Stimulation of human HEK-TLR2 cells
The HEK293 cell line harboring human TLR2 and the
secreted embryonic alkaline phosphate (SEAP) reporter gene fused
to NFkB was purchased commercially as HEK-BlueTM-hTLR2
from InvivoGen (USA). Cells were maintained and stimulated
using the culture media conditions specified by the manufacturer.
For this, Dulbecco’s modified Eagle’s media (DMEM) containing
4.5 g/l glucose was supplemented with 10% (v/v) heat-inactivated
fetal calf serum (FCS), 50 U/ml penicillin, 50 mg/ml streptomy-
cin, 2 mM L-glutamine, 100 mg/ml NormocinTM, and, when
required, HEK-BlueTM selection antibiotics. HEK-TLR2 cells
were seeded at cell densities of 5.06104 and 2.06105 in 96- and
24-well plates, respectively, using culture media with no selection
antibiotics. Cells from overnight cultures were stimulated with
bacteria at different multiplicity of infection (MOI) values (0.1 to
1000). NF-kB activation was observed to occur in a dose-
dependent manner, with the amount of bacteria triggering the
best response (MOI 100) then being chosen for use in the different
experiments, unless otherwise indicated. TLR2-stimulated activa-
tion of SEAP production in culture supernatants was itself
determined spectrophotometrically at 620 nm using QUANTI-
BlueTM detection medium according to the instructions recom-
mended by the manufacturer. Briefly, 20 ml of the stimulated cell
culture media (done in quadruplicate per different sample) were
added to the 96-well plate containing 180 ml of QUANTI-Blue
reagent, which was then incubated at 37uC. Color development
was monitored and the spectrophotometric measurements taken at
15-, 60-, 120-, and 180-minute time points. Production of IL-8 in
HEK-TLR2 cells was measured using the BD OptEIATM ELISA
kit according to the protocol recommended by the manufacturer
(BD Biosciences).
Isolation and generation of human moDCs
Purified primary monocytes were recovered from fresh leuko-
cyte-rich buffy coats, obtained from the donated blood of healthy
humans (Finnish Red Cross Blood Transfusion Service), according
to a method described earlier [52,53]. For this, removal of red
blood cells and the subsequent isolation of peripheral blood
mononuclear cells were carried out by using density gradient
centrifugation on Ficoll-Paque (GE Healthcare) with Leucosep
separation tubes (Greiner Bio-One, Germany), which was then
followed by PercollTM (GE Healthcare) gradient centrifugation.
Any remaining T- and B-cell lymphocytes were separated away by
using anti-CD3 and anti-CD9 magnetic beads (Dynal Invitrogen,
Norway). Isolation of monocytes was based on their plastic surface-
binding properties and carried out by allowing them to adhere to
6- or 24-well cell culture plates for one hour at 37uC with 5%
CO2, after which any nonadhering cells were aspirated away and
those cells still bound were rinsed twice with PBS. Adherent
monocytes were maintained for six days and allowed to
differentiate into dendritic cells in Roswell Park Memorial Institute
(RPMI) 1640 media (Sigma) containing 10% (v/v) FCS and
supplemented with 0.6 mg/ml penicillin, 60 mg/ml streptomycin,
2 mM L-glutamine, 20 mM HEPES, 10 ng/ml granulocyte
macrophage-colony stimulating factor (GM-CSF), and 20 ng/ml
IL-4 (GM-CSF and IL-4 were from Gibco, Sweden). Cells were
replenished with fresh media (1 ml/well) every two days. Cells had
displayed typical DC morphology and were found to be positive
for CD80 and CD86, but negative for CD14 and CD83 cell-
surface marker proteins (data not shown). Experiments were
performed with four different donors in RPMI 1640 media
containing 10% FCS, antibiotics, L-glutamine, and HEPES.
Stimulated cells and corresponding cell culture supernatants from
donor samples were collected and analyzed individually.
Stimulation of human moDCs
Cell suspensions of L. lactis and L. rhamnosus GG were
normalized (OD600) in RPMI 1640 media containing 10%
FCS, antibiotics, L-glutamine, and HEPES. Human moDCs were
treated with various amounts of bacteria (e.g., MOI 1, 10, and
100) and allowed to incubate at 37uC with 5% CO2 for about
24 hours. Cell culture supernatants were then collected and
measured for cytokines (TNF-a, IL-6, IL-10, and IL-12) using the
Bio-Plex Pro cytokine assay in the Bio-PlexTM-200 system
according to manufacturer recommended instructions (Bio-Rad,
UK).
Transwell assay analysis
Transwell (Corning, USA) cell culture membrane inserts (0.4-
mm pore size) were used to partition bacterial and human cells
from each other so as to prevent any direct physical interactions.
For this, the HEK-TLR2 cell line was seeded (2.06105) at the
bottom of 24-well plates and then allowed to grow overnight at
37uC in a 5% CO2 incubator. On the following day, overnight-
grown bacterial cells were rinsed twice with PBS and the cell
numbers were then adjusted to an OD600 of 0.5 (L. lactis) or 1.0 (L.
rhamnosus GG), with each being considered equivalent to 1.06109
cells/ml. Bacteria were added as a 100-ml volume directly to wells
containing the HEK-TLR2 cells or first to the transwell insert
compartment that was then submerged in wells with HEK-TLR2
cells. After ,24-hour incubation at 37uC with 5% CO2, each of
the supernatants was collected for QUANTI-Blue and IL-8 ELISA
analyses. Individual sample measurements were done in quadru-
plicate for the QUANTI-Blue determinations. For transwell
experiments with human moDCs, two 24-well plates, one with
transwell inserts (Becton Dickinson & Company, USA) and
another without, had been used, each of which contained an
initial monocyte density of ,1.256106 cells. DCs were stimulated
similarly with bacterial cells (see above) and cell culture
supernatants then collected for ELISA measurements.
Statistical analysis
All statistical analyses of data were performed using GraphPad
Prism (version 4.0). To support the statistical relevance of data
from experiments measuring mucus adhesion (Figure 2) and
induced TLR2-dependent activity (Figures 3-5), pairwise compar-
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isons were made using the unpaired Student’s t test. Calculated P
values were deemed significant (0.05 or less) or extremely
significant (0.001 or less). Donor-specific variation in moDCs
had prevented the reliable estimation of similar statistical
measurements for the cytokine production data in Figures 6 and 7.
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